Key Developments: Alere Inc (ALR.N)

ALR.N on New York Stock Exchange

38.40USD
19 Dec 2014
Price Change (% chg)

$0.42 (+1.11%)
Prev Close
$37.98
Open
$38.04
Day's High
$38.66
Day's Low
$38.04
Volume
156,966
Avg. Vol
141,365
52-wk High
$43.00
52-wk Low
$31.94

Search Stocks

Latest Key Developments (Source: Significant Developments)

Alere Inc declares cash dividend on Series B convertible perpetual preferred stock
Wednesday, 10 Dec 2014 05:30pm EST 

Alere Inc:Declares a cash dividend of $3.00 per share on its Series B Convertible Perpetual Preferred Stock.Payable on Jan. 15, 2015 to holders of record of Series B stock at the close of business on Jan. 2, 2015.  Full Article

Alere Inc announces U.S FDA grants CLIA waiver for Alere Determine HIV-1/2 Ag/Ab Combo Test
Tuesday, 9 Dec 2014 07:00am EST 

Alere Inc:Says U.S FDA has granted CLIA (Clinical Laboratory Improvement Amendments) Waiver for Alere Determine HIV-1/2 Ag/Ab Combo test.Until now, test has been available for sale in U.S to health facilities and laboratories licensed to conduct tests of moderate complexity.With this approval, test will now be available for use in physician offices, clinics and other public health settings as well.Alere Determine HIV 1-2 Ag/Ab Combo was FDA-approved in August 2013 as the first fourth-generation, rapid point-of-care test that detects both HIV-1/2 antibodies and free HIV-1 p24 antigen.Due to its capability to detect p24 antigen, which can appear in only days after infection and before the HIV antibody is detectable, Alere Determine HIV-1/2 Ag/Ab Combo may detect HIV infection earlier in the course of the disease.Earlier detection allows healthcare providers to improve clinical outcomes through earlier diagnosis and treatment of patients who test positive for HIV.  Full Article

Alere Inc announces appointment of Chief Executive Officer, President
Tuesday, 28 Oct 2014 07:30am EDT 

Alere Inc:Names Namal Nawana as the Chief Executive Officer, President, and a Member of the Board of Directors of Alere.  Full Article

Alere Inc secures U.S. Government contract to advance development of point of care molecular diagnostic for Pandemic Influenza
Wednesday, 1 Oct 2014 08:00am EDT 

Alere Inc:Says that it has entered into a contract with the U.S. Department of Health and Human Services' Biomedical Advanced Research and Development Authority (BARDA) to develop diagnostic countermeasures for pandemic influenza.Under the terms of the 3.5 year contract, BARDA will provide up to $12.9 million to support the development of a rapid, molecular, low-cost influenza diagnostic device with PCR-like performance at the point-of-care.The project is designed to help support future preparedness and medical response to an influenza pandemic.Funding from BARDA is subject to completion of various interim feasibility and development milestones as defined in the agreement.In connection with Alere's development of a rapid, molecular, low-cost influenza diagnostic device, Alere will be responsible for conducting clinical trials to support FDA 510 clearance and obtaining CLIA waiver as well as manufacturing and commercializing the resulting molecular influenza test.  Full Article

Alere Inc declares cash dividend on its series B convertible perpetual preferred stock
Tuesday, 2 Sep 2014 10:45pm EDT 

Alere Inc:Says that it has declared a cash dividend of $3.00 per share on its Series B Convertible Perpetual Preferred Stock.Says the dividend is payable on Oct. 15, 2014 to holders of record of Series B stock at the close of business on Oct. 1, 2014.  Full Article

Alere appoints interim chief executive and president
Tuesday, 1 Jul 2014 07:00am EDT 

Alere Inc:Ron Zwanziger resigns as chief executive officer, president and director effective immediately.Appoints chief operating officer Namal Nawana as interim chief executive and president.  Full Article

Alere Inc opts not to pursue initial public offering by BBI Diagnostics Group plc
Wednesday, 18 Jun 2014 11:30am EDT 

Alere Inc:Elects not to proceed at this time with its previously announced plans to pursue an initial public offering in the United Kingdom of the ordinary shares of BBI Diagnostics Group plc, or BBI Diagnostics.Intends to seek greater value for businesses of BBI Diagnostics than could be realized under current equity market conditions in the United Kingdom.Alere remains committed to its previously communicated strategy of divesting of non-core assets and to the use of proceeds from such divestitures to reduce its outstanding indebtedness.  Full Article

Alere Inc receives FDA clearance for Alere i Influenza A and B Test
Monday, 16 Jun 2014 08:30am EDT 

Alere Inc:Receives clearance from tU.S. Food and Drug Administration (FDA) for Alere i Influenza A & B test, the molecular test to detect and differentiate influenza A and B virus in less than 15 minutes.All specimens generating discrepant results between the Alere i Influenza A & B test and viral culture were tested using an FDA cleared RT-PCR assay to confirm influenza status.Molecular testing involves the extraction and analysis of DNA or RNA strands to detect sequences associated with viral and bacterial causes of infections.  Full Article

Alere Inc declares cash dividend on its series B convertible perpetual preferred stock
Thursday, 15 May 2014 06:08pm EDT 

Alere Inc:Declares cash dividend of $3.00 per share on its Series B Convertible Perpetual Preferred Stock.Dividend is payable on July 15, 2014 to holders of record of Series B stock at the close of business on July 1, 2014.  Full Article

Alere Inc initiates voluntary urgent product recall of Alere INRatio2 PT/INR
Tuesday, 6 May 2014 08:30am EDT 

Alere Inc:Initiated voluntary Class 1 recall in U.S. of Alere INRatio2 PT/INR Professional Test Strips (PN 99008G2).This action is result of complaints of patients who had therapeutic or near therapeutic INR with Alere INRatio2 PT/INR Professional Test Strip but significantly higher INR (outside of therapeutic range) when performed by central laboratory.  Full Article

Deals of the day- Mergers and acquisitions

(Adds SoftBank, JPMorgan Chase & Co, Zimmer Holdings, Vodafone Qatar, Volksbanken AG, Enel, UniCredit Bank Austria, Anadarko Petroleum and Alere)

Search Stocks